Close teamwork between Nrf2 and peroxiredoxins 1 and 6 for the regulation of prostaglandin D2 and E2 production in macrophages in acute inflammation

Free Radical Biology and Medicine

Volumn 88, Issue Part B, 2015, Pages 189-198

  Ishii, Tetsuro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

15d PGJ2; Free radicals; Lipocalin type prostaglandin D synthase; Lipopolysaccharide; NADPH oxidase 2; NF B; Nrf2; Peroxiredoxin; Polyphenols; Prostaglandin; S glutathionylation; Toll like receptor 4

Indexed keywords

CYCLOOXYGENASE 2; GLUTATHIONE; LIPOCALIN; PEROXIREDOXIN 1; PEROXIREDOXIN 2; PEROXIREDOXIN 6; POLYPHENOL; PROSTAGLANDIN D SYNTHASE; PROSTAGLANDIN D2; PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SELENIUM; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR NRF2; PEROXIREDOXIN;

BONE MARROW; CELL PROTECTION; INFLAMMATION; MACROPHAGE; OXIDATIVE STRESS; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; RAW 264.7 CELL LINE; REVIEW; ANIMAL; BIOSYNTHESIS; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; DINOPROSTONE; HUMANS; INFLAMMATION; MACROPHAGES; NF-E2-RELATED FACTOR 2; PEROXIREDOXINS; PROSTAGLANDIN D2; SIGNAL TRANSDUCTION;

EID: 84976315921     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.04.034     Document Type: Review

References (111)

1. [1] Nathan, C, Cunningham-Bussel, A., Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nat. Rev. Immunol. 13 (2013), 349–361.
2. [2] Newton, K, Dixit, VM., Signaling in innate immunity and inflammation. Cold Spring Harbor Perspect. Biol., 4, 2012, a006049.
3. [3] Mittal, M, Siddiqui, MR, Tran, K, Reddy, SP, Malik, AB., Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signaling 20 (2014), 1126–1167.
4. [4] Hoesel, B, Schmid, JA., The complexity of NF-κB signaling in inflammation and cancer. Mol. Cancer, 12, 2013, 86.
5. [5] Korbecki, J, Baranowska-Bosiacka, I, Gutowska, I, Chlubek, D., The effect of reactive oxygen species on the synthesis of prostanoids from arachidonic acid. J. Physiol. Pharmacol. 64 (2013), 409–421.
6. [6] Itoh, K, Chiba, T, Takahashi, S, Ishii, T, Igarashi, K, Katoh, Y, Oyake, T, Hayashi, N, Satoh, K, Hatayama, I, Yamamoto, M, Nabeshima, Y., An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236 (1997), 313–322.
7. [7] Ishii, T, Itoh, K, Takahashi, S, Sato, H, Yanagawa, T, Katoh, Y, Bannai, S, Yamamoto, M., Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 275 (2000), 16023–16029.
8. [8] Zhang, X, Lu, L, Dixon, C, Wilmer, W, Song, H, Chen, X, Rovin, BH., Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 human mesangial cells. Kidney Int. 65 (2004), 798–810.
9. 2. Mol. Cell. Biol. 24 (2004), 36–45.
10. 2 and Nrf2 pathways in protection against acute lung injury. Am. J. Respir. Crit. Care Med. 171 (2005), 1260–1266.
11. 2. J. Lipid Mediators Cell Signalling 12 (1995), 443–448.
12. [12] Jiang, C, Ting, T, Seed, B., PPAR-γ agonist inhibits production of monocyte inflammatory cytokines. Nature 391 (1998), 82–86.
13. [13] Rossi, A, Kapahi, P, Natoli, T, Takahashi, T, Chen, Y, Karin, M, Santoro, MG., Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature 403 (2000), 103–108.
14. 2. Free Radic. Biol. Med. 65 (2013), 1134–1142.
15. [15] Bhattacharyya, S, Gill, R, Chen, ML, Zhang, F, Linhardt, RJ, Dudeja, PK, Tobacman, JK., Toll-like receptor 4 mediates induction of the Bcl10–NFκB–interleukin-8 inflammatory pathway by carrageenan in human intestinal epithelial cells. J. Biol. Chem. 283 (2008), 10550–10558.
16. [16] Tomlinson, A, Appleton, I, Moore, AR, Gilroy, DW, Willis, D, Mitchell, JA, Willoughby, DA., Cyclo-oxygenase and nitric oxide synthase isoforms in rat carrageenan-induced pleurisy. Br. J. Pharmacol. 113 (1994), 693–698.
17. [17] Katori, M, Harada, Y, Hatanaka, K, Majima, M, Kawamura, M, Ohno, T, Aizawa, A, Yamamoto, S., Induction of prostaglandin H synthase-2 in rat carrageenan-induced pleurisy and effect of a selective COX-2 inhibitor. Adv. Prostaglandin Thromboxane Leukotriene Res 23 (1995), 345–346.
18. [18] Ortega-Gόmez, A, Perretti, M, Soehnlein, O., Resolution of inflammation: an integrated view. EMBO Mol. Med 5 (2013), 661–674.
19. [19] Geering, B, Simon, HU., Peculiarities of cell death mechanisms in neutrophils. Cell Death Differ. 18 (2011), 1457–1469.
20. [20] Ishii, T, Itoh, K, Ruiz, E, Leake, DS, Unoki, H, Yamamoto, M, Mann, GE., Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ. Res. 94 (2004), 609–616.
21. [21] Jeyapaul, J, Jaiswal, AK., Nrf2 and c-Jun regulation of antioxidant response element (ARE)-mediated expression and induction of gamma-glutamylcysteine synthetase heavy subunit gene. Biochem. Pharmacol. 59 (2000), 1433–1439.
22. [22] Chowdhury, I, Mo, Y, Gao, L, Kazi, A, Fisher, AB, Feinstein, SI., Oxidant stress stimulates expression of the human peroxiredoxin 6 gene by a transcriptional mechanism involving an antioxidant response element. Free Radic. Biol. Med. 46 (2009), 146–153.
23. 2, and protein chaperones. Antioxid. Redox Signaling 15 (2011), 781–794.
24. [24] Riddell, JR, Wang, X-Y, Minderman, H, Gollnick, SO., Peroxiredoxin 1 stimulates secretion of proinflammatory cytokines by binding to TLR4. J. Immunol. 184 (2010), 1022–1030.
25. [25] Shichita, T, Hasegawa, E, Kimura, A, Morita, R, Sakaguchi, R, Takada, I, Sekiya, T, Ooboshi, H, Kitazono, T, Yanagawa, T, Ishii, T, Takahashi, H, Mori, S, Nishibori, M, Kuroda, K, Akira, S, Miyake, K, Yoshimura, A., Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat. Med 18 (2012), 911–917.
26. [26] El Eter, E, Al Masri, A, Habib, S, Al Zamil, H, Al Hersi, A, Ai Hussein, F, Al Omran, M., Novel links among peroxiredoxins, endothelial dysfunction, and severity of atherosclerosis in type 2 diabetic patients with peripheral atherosclerotic disease. Cell Stress Chaperones 19 (2014), 173–181.
27. [27] Ishii, T, Yanagawa, T, Warabi, E., Novel roles of peroxiredoxins in inflammation, cancer and innate immunity. J. Clin. Biochem. Nutrition 50 (2012), 91–105.
28. [28] Mullen, L, Hanschmann, EM, Lillig, CH, Herzenberg, LA, Ghezzi, P., Cysteine oxidation targets peroxiredoxins 1 and 2 for exosomal release through a novel mechanism of redox-dependent secretion. Mol. Med., 21, 2015, 98–108.
29. [29] Yanagisawa, R, Warabi, E, Inoue, K, Yanagawa, T, Koike, E, Ichinose, T, Takano, H, Ishii, T., Peroxiredoxin I null mice exhibits reduced acute lung inflammation following ozone exposure. J. Biochem. 152 (2012), 595–601.
30. [30] Fisher, AB., Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. Antioxid. Redox Signaling 15 (2011), 831–844.
31. 2 activities of peroxiredoxin 6 in protecting pulmonary microvascular endothelial cells against peroxidative stress. Antioxid. Redox Signaling 16 (2012), 440–451.
32. [32] Ambruso, DR, Ellison, MA, Thurman, GW, Leto, TL., Peroxiredoxin 6 translocates to the plasma membrane during neutrophil activation and is required for optimal NADPH oxidase activity. Biochem. Biophys. Acta 1823 (2012), 306–315.
33. [33] Korbecki, J, Baranowska-Bosiacka, I, Gutowska, I, Chlubek, D., The effect of reactive oxygen species on the synthesis of prostanoids from arachidonic acid. J. Physiol. Pharmacol. 64 (2013), 409–421.
34. 2 on arachidonic acid release induced by reactive oxygen species. Arch. Biochem. Biophys. 392 (2001), 257–262.
35. [35] Ishii, T, Mann, GE., Redox status in mammalian cells and stem cells during culture in vitro: critical roles of Nrf2 and cystine transporter activity in the maintenance of redox balance. Redox Biol 2 (2014), 786–794.
36. [36] Pastore, A, Piemonte, F., Protein glutathionylation in cardiovascular diseases. Int. J. Mol. Sci 14 (2013), 20845–20876.
37. [37] Ullevig, S, Kim, HS, Asmis, R., S-glutathionylation in monocyte and macrophage (dys)function. Int. J. Mol. Sci 14 (2013), 15212–15232.
38. [38] Grek, CL, Zhang, J, Manevich, Y, Townsend, DM, Tew, KD., Causes and consequences of cysteine S-glutathionylation. J. Biol. Chem. 288 (2013), 26497–26504.
39. [39] Mailloux, RJ, Willmore, WG., S-glutathionylation reactions in mitochondrial function and disease. Front. Cell. Dev. Biol, 2, 2014, 68.
40. [40] Tew, KD., Redox in redux: emergent roles for glutathione S-transferase P (GSTP) in regulation of cell signaling and S-glutathionylation. Biochem. Pharmacol. 73 (2007), 1257–1269.
41. [41] Rhee, SG, Yang, KS, Kang, SW, Woo, HA, Chang, TS., Controlled elimination of intracellular H2O2: regulation of peroxiredoxin, catalase, and glutathione peroxidase via post-translational modification. Antioxid. Redox Signaling 7 (2005), 619–626.
42. [42] Chae, HZ, Oubrahim, H, Park, JW, Rhee, SG, Chock, PB., Protein glutathionylation in the regulation of peroxiredoxins: a family of thiol-specific peroxidase that function as antioxidants, molecular chaperones, and signal modulators. Antioxid. Redox Signaling 16 (2012), 506–523.
43. [43] Park, JW, Piszczek, G, Rhee, SG, Chock, PB., Glutathionylation of peroxiredoxin I induces decamer to dimers dissociation with concomitant loss of chaperone activity. Biochemistry 50 (2011), 3204–3210.
44. [44] Park, JW, Mieyal, JJ, Rhee, SG, Chock, PB., Deglutathionylation of 2-Cys peroxiredoxin is specifically catalyzed by sulfiredoxin. J. Biol. Chem. 284 (2009), 23364–23374.
45. [45] Salzano, S, Checconi, P, Hanschmann, E-M, Lillig, CH, Bowler, LD, Chan, P, Vaudry, D, Mengozzi, M, Coppo, L, Sacre, S, Atkuri, KR, Sahaf, B, Herzenberg, LA, Herzenberg, LA, Mullen, L, Ghezzi, P., Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal. Proc. Natl. Acad. Sci. USA 111 (2014), 12157–12162.
46. [46] Parmigiani, RB, Xu, WS, Venta-Perez, G, Erdjument-Bromage, H, Yaneva, M, Tempst, P, Marks, PA., HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation. Proc. Natl. Acad. Sci. USA 105 (2008), 9633–9638.
47. [47] Woo, HA, Kang, SW, Kim, HK, Yang, K-S, Chae, HZ, Rhee, SG., Reversible oxidation of the active site cysteine of peroxiredoxins to cysteine sulfinic acid: immunoblot detection with antibodies specific for the hyperoxidized cysteine-containing sequence. J. Biol. Chem. 278 (2003), 47361–47364.
48. [48] Bast, A, Erttmann, SF, Walther, R, Steinmetz, I., Influence of iNOS and COX on peroxiredoxin gene expression in primary macrophages. Free Radic. Biol. Med. 49 (2010), 1881–1891.
49. [49] Da Silva Correia, J, Soldau, K, Christen, U, Tobias, PS, Ulevitch, RJ., Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex: transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 276 (2001), 21129–21135.
50. [50] Shuto, T, Kato, K, Mori, Y, Viriyakosol, S, Oba, M, Furuta, T, Okiyoneda, T, Arima, H, Suico, MA, Kai, H., Membrane-anchored CD14 is required for LPS-induced TLR4 endocytosis in TLR4/MD-2/CD14 overexpressing CHO cells. Biochem. Biophys. Res. Commun. 338 (2005), 1402–1409.
51. [51] Scott, MJ, Billiar, TR., Beta2-integrin-induced p38 MAPK activation is a key mediator in the CD14/TLR4/MD2-dependent uptake of lipopolysaccharide by hepatocytes. J. Biol. Chem. 283 (2008), 29433–29446.
52. [52] Powers, KA, Szászi, K, Khadaroo, RG, Tawadros, PS, Marshall, JC, Kapus, A, Rotstein, OD., Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages. J. Exp. Med. 203 (2006), 1951–1961.
53. [53] Sichita, T, Sugiyama, Y, Ooboshi, H, Sugimori, H, Nakagawa, R, Takada, I, Iwaki, T, Okada, Y, Iida, M, Cua, DJ, Iwakura, Y, Yoshimura, A., Pivotal role of cerebral interleukin-17-producing γδT cells in the delayed phase of ischemic brain injury. Nat. Med 15 (2009), 946–950.
54. [54] Guo, Y, Ma, SF, Grigoryev, D, Van Eyk, J, Barcia, JG., 1-DE MS and 2-D LC-MS analysis of the mouse bronchoalveolar lavage proteome. Proteomics 5 (2005), 4608–4624.
55. [55] Manevich, Y, Sweitzer, T, Pak, JH, Feinstein, SI, Muzykantov, V, Fisher, AB., 1-Cys peroxiredoxin overexpression protects cells against phospholipid peroxidation-mediated membrane damage. Proc. Natl. Acad. Sci. USA 99 (2002), 11599–11604.
56. [56] Zhou, S, Lien, Y-C, Shuvaeva, T, DeBolt, K, Feinstein, SI, Fisher, AB., Functional interaction of glutathione S-transferase pi and peroxiredoxin 6 in intact cells. Int. Biochem. Cell Biol. 45 (2013), 401–407.
57. [57] Liu, G, Feinstein, SI, Wang, Y, Dodia, C, Fisher, D, Yu, K, Ho, YS, Fisher, AB., Comparison of glutathione peroxidase 1 and peroxiredoxin 6 in protection against stress in the mouse lung. Free Radic. Biol. Med. 49 (2010), 1172–1181.
58. [58] Kim, HS, Manevich, Y, Feinstein, SI, Pak, JH, Ho, YS, Fisher, AB., Induction of 1-Cys peroxiredoxin expression by oxidative stress in lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol 285 (2003), L363–369.
59. [59] Chowdhury, I, Fisher, AB, Christofidou-Solomidou, M, Tao, JQ, Sorokina, EM, Lien, YC, Bates, SR, Feinstein, SI., Keratinocyte growth factor and glucocorticoid induction of human peroxiredoxin 6 gene expression occur by independent mechanisms that are synergistic. Antioxid. Redox Signaling 20 (2014), 391–402.
60. [60] Rada, B, Leto, TL., Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib. Microbiol 15 (2008), 164–187.
61. [61] Zhao, X, Xu, B, Bhattacharjee, A, Oldfield, CM, Wientjes, FB, Feldman, GM, Cathcart, MK., Protein kinase Cδ regulates p67phox phosphorylation in human monocytes. J. Leukocyte Biol. 77 (2005), 414–420.
62. 2-derived signal for activation of NADPH oxidase (NOX2). FASEB J 27 (2013), 2066–2073.
63. 2 activity are required for agonist-mediated activation of NADPH oxidase in mouse pulmonary microvascular endothelium and alveolar macrophages. J. Biol. Chem. 286 (2011), 11696–11706.
64. 2 activity. Biochem. J. 419 (2009), 669–679.
65. 2-dependent hyperoxidation of peroxiredoxin 6 (Prdx6) plays a role in cellular toxicity via up-regulation of iPLA2 activity. J. Biol. Chem. 283 (2008), 33563–33568.
66. 2 of bovine lung. Comp. Biochem. Physiol. B Biochem. Mol. Biol 120 (1998), 393–404.
67. 2 subclasses in acute respiratory distress syndrome. Biochim. Biophys. Acta 1792 (2009), 941–953.
68. [68] Menden, H, Tate, E, Hogg, N, Sampath, V., LPS-mediated endothelial activation in pulmonary endothelial cells: role of Nox2-dependent IKK-β phosphorylation. Am. J. Physiol. Lung Cell. Mol. Physiol 304 (2013), L445–455.
69. [69] Nishimoto, Y, Diebold, BA, Cosentino-Gomes, D, Lambeth JD. Nox4: a hydrogen peroxide-generating oxygen sensor. Biochemistry 53 (2014), 5111–5120.
70. [70] Park, HS, Jung, HY, Park, EY, Kim, J, Lee, WJ, Bae, YS., Direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-κB. J. Immunol. 173 (2004), 3589–3593.
71. [71] Lee, I, Dodia, C, Chatterjee, S, Feinstein, SI, Fisher, AB., Protection against LPS-induced acute lung injury by a mechanism-based inhibitor of NADPH oxidase (type 2). Am. J. Physiol. Lung Cell. Mol. Physiol 306 (2014), L635–644.
72. [72] Yang, D, Song, Y, Wang, X, Sun, J, Ben, Y, An, X, Tong, L, Bi, J, Wang, X, Bai, C., Deletion of peroxiredoxin 6 potentiates lipopolysaccharide-induced acute lung injury in mice. Crit. Care Med. 39 (2011), 756–764.
73. [73] Clark, JD, Schievella, AR, Nalefski, EA, Lin, LL., Cytosolic phospholipase A2. J. Lipid Mediators Cell Signalling 12 (1995), 83–117.
74. 2. Cell Signalling 14 (2002), 199–204.
75. 2 in U937 cells: requirement for a Gi alpha-type G-protein. Biochim. Biophys. Acta 134 (1997), 223–237.
76. [76] Ricciotti, E, FitzGerald, GA., Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 31 (2011), 986–1000.
77. [77] Norberg, JK, Sells, E, Chang, H-H, Alla, SR, Zhang, S, Meuillet, EJ., Targeting inflammation: multiple innovative ways to reduce prostaglandin E2. Pharm. Pat. Anal 2 (2013), 265–288.
78. [78] Kobayashi, M, Li, L, Iwamoto, N, Nakajima-Takagi, Y, Kaneko, H, Nakayama, Y, Eguchi, M, Wada, Y, Kumagai, Y, Yamamoto, M., The antioxidant defense system Keap1–Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Mol. Cell. Biol. 29 (2009), 493–502.
79. 2 in MCF7 breast cancer cells. Biochemistry 42 (2003), 5429–5437.
80. [80] Bogaards, JJ, Venekamp, JC, van Bladeren, PJ., Stereoselective conjugation of prostaglandin A2 and prostaglandin J2 with glutathione, catalyzed by the human glutathione S-transferases A1-1, A2-2, M1a-1a, and P1-1. Chem. Res. Toxicol. 10 (1997), 310–317.
81. [81] Paumi, CM, Smitherman, PK, Townsend, AJ, Morrow, CS., Glutathione S-transferases, (GSTs), inhibit transcriptional activation by the peroxisomal proliferator-activated receptor gamma (PPARγ) ligand, 15-d-∆12,14prostaglandin J2 (15-d-PGJ2). Biochemistry 43 (2004), 2345–2352.
82. [82] Xiao, L, Ornatowska, M, Zhao, G, Cao, H, Yu, R, Deng, J, Li, Y, Zhao, Q, Sadikot, RT, Christman, JW., Lipopolysaccharide-induced expression of microsomal prostaglandin E synthase-1 mediates late-phase PGE2 production in bone marrow derived macrophages. PLoS One, 7, 2012, e50244.
83. [83] Díaz-Muñoz, MD, Osma-Garcia, IC, Cacheiro-Llaguno, C, Fresno, M, Iñiquez, MA., Coordinated up-regulation of cyclooxygenase-2 and microsomal prostaglandin E synthase 1 transcription by nuclear factor kappa B and early growth response-1 in macrophages. Cell. Signalling 22 (2010), 1427–1436.
84. [84] Jakobsson, PJ, Thorén, S, Morgenstern, R, Samuelsson, B., Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc. Natl. Acad. Sci. USA 96 (1999), 7220–7225.
85. [85] Bresell, A, Weinander, R, Lundqvist, G, Raza, H, Shimoji, M, Sun, TH, Balk, L, Wiklund, R, Eriksson, J, Jansson, C, Persson, B, Jakobsson, PJ, Morgenstern, R., Bioinformatic and enzymatic characterization of the MAPEG superfamily. FEBS J. 272 (2005), 1688–1703.
86. [86] Díaz-Muñoz, MD, Osma-Garcia, IC, Fresno, M, Iñiquez, MA., Involvement of PGE2 and the cAMP signaling pathway in the upregulation of COX-2 and mPGES-1 expression in LPS-activated macrophages. Biochem. J. 443 (2012), 451–461.
87. [87] Nishimura, T, Zhao, X, Gan, H, Koyasu, S, Remold HG. The prostaglandin E2 receptor EP4 is integral to a positive feedback loop for prostaglandin E2 production in human macrophages infected with Mycobacterium tuberculosis. FASEB J 27 (2013), 3827–3836.
88. [88] Zhao, G, Yu, R, Deng, J, Zhao, Q, Li, Y, Joo, M, van Breemen, RB, Christman, JW, Xiao, L., Pivotal role of reactive oxygen species in differential regulation of lipopolysaccharide-induced prostaglandins production in macrophages. Mol. Pharmacol. 83 (2013), 167–178.
89. [89] Thomson, AM, Meyer, DJ, Hayes, JD., Sequence, catalytic properties and expression of chicken glutathione-dependent prostaglandin D2 synthase, a novel class Sigma glutathione S-transferase. Biochem. J. 333 (1998), 317–325.
90. [90] Jowsey, IR, Thomson, AM, Flanagan, JU, Murdock, PR, Moore, GB, Meyer, DJ, Murphy, GJ, Smith, SA, Hayes, JD., Mammalian class Sigma glutathione S-transferases: catalytic properties and tissue-specific expression of human and rat GSH-dependent prostaglandin D2 synthases. Biochem. J. 359 (2001), 507–516.
91. 2+. J. Inorg. Biochem. 104 (2010), 331–340.
92. [92] Allegra, M, D'Acquisto, F, Tesoriere, L, Attanzio, A, Livrea, MA., Pro-oxidant activity of indicaxanthin from Opuntia ficus indica modulates arachidonate metabolism and prostaglandin synthesis through lipid peroxide production in LPS-stimulated RAW264.7 macrophages. Redox Biol 2 (2014), 892–900.
93. 2 production in biological fluids. Anal. Biochem. 372 (2008), 41–51.
94. [94] Sasaki, H, Yamamoto, H, Tominaga, K, Masuda, K, Kawai, T, Teshima-Kondo, S, Rokutan, K., NADPH oxidase-derived reactive oxygen species are essential for differentiation of a mouse macrophage cell line (RAW264.7) into osteoclasts. J. Med. Invest. 56 (2009), 33–41.
95. [95] Ikeda, Y, Murakami, A, Ohigashi, H., Strain differences regarding susceptibility to ursolic acid-induced interleukin-1β release in murine macrophages. Life Sci. 83 (2008), 43–49.
96. [96] Allegra, M, Ianaro, A, Tersigni, M, Panza, E, Tesoriere, L, Livrea, MA., Indicaxanthin from cactus pear fruit exerts anti-inflammatory effects in carrageenan-induced rat pleurisy. J. Nutr. 144 (2014), 185–192.
97. [97] Gandhi, UH, Kaushal, N, Ravindra, KC, Hegde, S, Nelson, SM, Narayan, V, Vunta, H, Paulson, RF, Prabhu, KS., Selenoprotein-dependent up-regulation of hematopoietic prostaglandin D2 synthase in macrophages is mediated through the activation of peroxisome proliferator-activated receptor (PPAR) γ. J. Biol. Chem. 286 (2011), 27471–27482.
98. [98] Joo, M, Sadikot, RT., PGD synthases and PGD2 in immune response. Mediators Inflammation, 2012, 2012, 503128.
99. [99] Joo, M, Kwon, M, Cho, Y-J, Hu, N, Pedchenko, TV, Sadikot, RT, Blackwell, TS, Christman, JW., Lipopolysaccharide-dependent interaction between PU.1 and cJun determines production of lipocalin-type prostaglandin D synthase and prostaglandin D2 in macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol 296 (2009), L771–779.
100. 2. Free Radic. Biol. Med. 65 (2013), 1134–1142.
101. [101] Katsumata, Y, Shinmura, K, Sugiura, Y, Tohyama, S, Matsuhashi, T, Ito, H, Yan, X, Ito, K, Yuasa, S, Ieda, M, Urade, Y, Suematsu, M, Fukuda, K, Sano, M., Endogenous prostaglandin D2 and its metabolisms protect the heart against ischemia–reperfusion injury by activating Nrf2. Hypertension 263 (2014), 80–87.
102. [102] Tokudome, S, Sano, M, Shinmura, K, Matsuhashi, T, Morizane, S, Moriyama, H, Tamaki, K, Hayashida, K, Nakanishi, H, Yoshikawa, N, Shimizu, N, Endo, J, Katayama, T, Murata, M, Yuasa, S, Kaneda, R, Tomita, K, Eguchi, N, Urade, Y, Asano, K, Utsunomiya, Y, Suzuki, Y, Taguchi, R, Tanaka, H, Fukuda, K., Glucocorticoid protects rodent hearts from ischemia/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis. J. Clin. Invest. 119 (2009), 1477–1488.
103. [103] Gonzalez-Rodriguez, PJ, Li, Y, Martinez, F, Zhang, L., Dexamethasone protects neonatal hypoxic–ischemic brain injury via L-PGDS-dependent PGD2–DP1–pERK signaling pathway. PLoS One, 9, 2014, e114470.
104. [104] Benito-Martin, A, Giannatale, AD, Ceder, S, Peinado, H., The new deal: a potential role for secreted vesicles in innate immunity and tumor progression. Front. Immunol, 6, 2015, 66.
105. [105] D'Incá, F, Pucillo, CE., Exosomes: tiny clues for mast cell communication. Front. Immunol, 6, 2015, 73.
106. [106] Sauri, H, Ashjian, PH, Kim, AT, Shau, H., Recombinant natural killer enhancing factor augments natural killer cytotoxicity. J. Leukocyte Biol. 59 (1996), 925–931.
107. [107] Geiben-Lynn, R, Kursar, M, Brown, NV, Addo, MM, Shau, H, Lieberman, J, Luster AD, Walker BD. HIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin family. J. Biol. Chem. 278 (2003), 1569–1574.
108. [108] Kimura, S, Warabi, E, Yanagawa, T, Ma, D, Itoh, K, Ishii, S, Kawachi, Y, Ishii, T., Essential role of Nrf2 in keratinocyte protection from UVA by quercetin. Biochem. Biophys. Res. Commun. 387 (2009), 109–114.
109. [109] Barbagallo, I, Galvano, F, Frigiola, A, Cappello, F, Riccioni, G, Murabito, P, D'Orazio, N, Torella, M, Gazzolo, D, Li Volti, G., Potential therapeutic effects of natural heme oxygenase-1 inducers in cardiovascular diseases. Antioxid. Redox Signaling 18 (2013), 507–521.
110. [110] Stepanic, V, Gasparovic, AC, Troselj, KG, Amic, D, Zarkovic, N., Selected attributes of polyphenols in targeting oxidative stress in cancer. Curr. Top. Med. Chem. 15 (2015), 496–509.
111. [111] Eo, S-H, Cho, H-S, Kim, S-J., Resveratrol regulates type II collagen and COX-2 expression via the ERK, p38 and Akt signaling pathways in rabbit articular chondrocytes. Exp. Ther. Med 7 (2014), 640–648.